NCT07714291Not yet recruiting
CPHARM - CRC Study
Community Pharmacy-Based Health-Seeking Behaviour and Colorectal Cancer Screening Uptake Among Malaysian Adults
Source: ClinicalTrials.gov · Last updated 21 Jul 2026
Brief summary (registry, in English)
Colorectal cancer is one of the most common cancers in Malaysia and worldwide. Although it can often be prevented or treated successfully when detected early, many people in Malaysia are diagnosed at an advanced stage. Screening tests, such as the immunochemical faecal occult blood test (iFOBT), can help detect early signs of colorectal cancer; however, participation in screening remains low. Community pharmacies are easily accessible healthcare settings where people frequently seek health advice. Pharmacists may play an important role in improving awareness and encouraging colorectal cancer screening by providing education and support. However, more information is needed to understand how people perceive and respond to pharmacy-based colorectal cancer screening.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 316 (estimated)
- First submitted
- 15 Jul 2026
- Start date
- 1 Nov 2026
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Monash University Malaysia
- Diseases
- Colorectal cancer
- NCT number
- NCT07714291
What you commit to
- Study type: Interventional
- Planned participants: 316
- From 1 Nov 2026 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of colorectal cancer
Other illness
- History of colonoscopy within the recommended screening interval (within past 1 year)
- Currently experiencing symptoms suggestive of colorectal cancer
- Having a first-degree relative diagnosed with colorectal cancer
Who the study is looking for
- Adults aged 50 to 75 years
- Visiting participating community pharmacies during the study period
- Able to provide informed consent
- Willing to complete the study questionnaire
- Willing to provide consent for follow-up assessment of: iFOBT provision, iFOBT testing completion, iFOBT results
Age in the registry: 50 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Big Caring Group Coordinator of this site? Confirm its status | Klang | Malaysia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.